A review from Brazil demonstrated that cabergoline induced prolactin normalization in 86% of treatment naïve prolactinoma patients overall (91% in patients with microadenoma, 83% in macroadenoma) and resulted in tumor shrinkage in 80% of treatment naïve macroprolactinomas [44]. The gene discussed is PRL; the disease is neoplasm.